Healio

FDA approves updated label with new dosing guidance for inhaled insulin

The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...

FDA approves drug to treat dogs with idiopathic epilepsy

The U.S. Food and Drug Administration (FDA) has approved a drug to control seizures in dogs with idiopathic epilepsy, a type ...
CURE

FDA Approves Larger Nelarabine Vial for Some Leukemias and Lymphomas

The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...
CURE

FDA Approves Darzalex Faspro-VRd For Newly Diagnosed, Transplant Ineligible Multiple Myeloma

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for ...
Ophthalmology Times

FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
Politifact

A product says it's ‘FDA approved,’ ‘FDA registered’ or ‘FDA certified.’ What does that even mean?

An Instagram ad catches your eye. You click to the product’s website and find reassurance: The product, it says, is "FDA certified" or was "produced in an FDA registered facility." Mention of the U.S.
AOL

8 FDA-approved weight loss drugs: What are they & what are their side effects?

Most weight loss drugs are FDA-approved for people with obesity or overweight with a weight-related health condition. A healthcare provider can help you find the best weight loss medication for you.
Healio

Q&A: Eye care practitioners urge FDA to approve low-dose atropine

A Change.org petition with more than 800 signatures is calling on the FDA to approve low-dose atropine to slow the ...

Assessing Guardant Health (GH) Valuation After FDA Guardant360 CDx Approval And New Merck Collaboration

Guardant Health (GH) is back in focus after the FDA approved its Guardant360 CDx liquid biopsy as a companion diagnostic for BRAF V600E-mutant metastatic colorectal cancer and the company announced a ...